Belantamab Mafodotin detection by protein electrophoresis: Assessing interference for defining clinical response.

被引：0
|
作者：
McClure, Fiona J. [1 ]
机构：
[1] GSK, Stevenage, Herts, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
407
引用
收藏
页数：1
相关论文
共 27 条
  • [21] Development of clinical assay to mitigate daratumumab, an IgG1κ monoclonal antibody, interference with serum immunofixation (IFE) and clinical assessment of M-protein response in multiple myeloma
    Axel, Amy E.
    McCudden, Christopher R.
    Xie, Hong
    Hall, Brett M.
    Sasser, A. Kate
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Detection of Polyclonal Increases in Immunoglobulin G4 Subclass by Distinct Patterns on Capillary Serum Protein Electrophoresis Diagnostic Pitfalls and Clinical Observations in a Study of 303 Cases
    Finn, William G.
    Gulbranson, Ronald
    Fisher, Sondra
    Sample, Lynn Rae
    Shalhoub, Renee
    Hedstrom, Deborah
    Keren, David F.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (03) : 303 - 311
  • [23] Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents
    Shirouchi, Yuko
    Kaihara, Kazumi
    Sekita, Tsunaki
    Amano, Naoko
    Nakayama, Konosuke
    Miyake, Kazunori
    Abe, Hitoshi
    Oinuma, Hirotoshi
    Maruyama, Dai
    CANCER MEDICINE, 2024, 13 (16):
  • [24] Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA 3 BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data
    Gottlieb, Alice B.
    Merola, Joseph F.
    Chen, Rongdean
    Levi, Eugenia
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (06) : 1178 - 1180
  • [25] A Novel Detection Methodology for HER2 Protein Quantitation in Clinical Samples: Correlation with Pathologic Response to Trastuzumab-Based Neoadjuvant Therapy
    Turner, Bradley M.
    Buscaglia, Brandon
    Goda, Hideki
    Mcmahon, Loralee
    Natori, Takako
    Okada, Hisatake
    Soukiazian, Armen
    Nakano, Yasushi
    Hicks, David
    LABORATORY INVESTIGATION, 2018, 98 : 110 - 111
  • [26] A Novel Detection Methodology for HER2 Protein Quantitation in Clinical Samples: Correlation with Pathologic Response to Trastuzumab-Based Neoadjuvant Therapy.
    Turner, Bradley M.
    Buscaglia, Brandon
    Goda, Hideki
    Mcmahon, Loralee
    Natori, Takako
    Okada, Hisatake
    Soukiazian, Armen
    Nakano, Yasushi
    Hicks, David
    MODERN PATHOLOGY, 2018, 31 : 110 - 111
  • [27] Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody.
    McCudden, Christopher
    Axel, Amy
    Slaets, Dominique
    Frans, Sandy
    Bald, Jaime
    Schecter, Jordan Mark
    Ahmadi, Tahamtan
    Plesner, Torben
    Sasser, Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
123